GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (XCNQ:PREV) » Definitions » EV-to-FCF

PreveCeutical Medical (XCNQ:PREV) EV-to-FCF : -76.95 (As of May. 21, 2024)


View and export this data going back to 2016. Start your Free Trial

What is PreveCeutical Medical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PreveCeutical Medical's Enterprise Value is C$17.16 Mil. PreveCeutical Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.22 Mil. Therefore, PreveCeutical Medical's EV-to-FCF for today is -76.95.

The historical rank and industry rank for PreveCeutical Medical's EV-to-FCF or its related term are showing as below:

XCNQ:PREV' s EV-to-FCF Range Over the Past 10 Years
Min: -76.95   Med: 0   Max: 0
Current: -76.95

XCNQ:PREV's EV-to-FCF is ranked worse than
100% of 379 companies
in the Biotechnology industry
Industry Median: 8.34 vs XCNQ:PREV: -76.95

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), PreveCeutical Medical's stock price is C$0.025. PreveCeutical Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.000. Therefore, PreveCeutical Medical's PE Ratio for today is N/A.


PreveCeutical Medical EV-to-FCF Historical Data

The historical data trend for PreveCeutical Medical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PreveCeutical Medical EV-to-FCF Chart

PreveCeutical Medical Annual Data
Trend Jul15 Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Get a 7-Day Free Trial -3.05 -12.71 284.20 -32.65 -73.40

PreveCeutical Medical Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.39 -93.33 -30.64 -73.40 87.00

Competitive Comparison of PreveCeutical Medical's EV-to-FCF

For the Biotechnology subindustry, PreveCeutical Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PreveCeutical Medical's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where PreveCeutical Medical's EV-to-FCF falls into.



PreveCeutical Medical EV-to-FCF Calculation

PreveCeutical Medical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=17.159/-0.223
=-76.95

PreveCeutical Medical's current Enterprise Value is C$17.16 Mil.
PreveCeutical Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PreveCeutical Medical  (XCNQ:PREV) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PreveCeutical Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.025/0.000
=N/A

PreveCeutical Medical's share price for today is C$0.025.
PreveCeutical Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


PreveCeutical Medical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PreveCeutical Medical (XCNQ:PREV) Business Description

Traded in Other Exchanges
Address
885 Cambie Street, Suite 2500, Vancouver, BC, CAN, V6B 0R6
PreveCeutical Medical Inc is a health sciences company. Its principal business activity is the development of innovative options for preventive and curative therapies utilizing organic and nature-identical products. It is engaged in licensing, branding, and marketing nutraceutical and wellness products.

PreveCeutical Medical (XCNQ:PREV) Headlines

No Headlines